Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

NCT01441596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Neoplasm Metastasis

Interventions

DRUG: Vinorelbine
DRUG: Investigator's choice of treatment
DRUG: afatinib
DRUG: afatinib

Sponsor

Boehringer Ingelheim